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Background: Health administrative data is increasingly being used for chronic disease surveillance. This study
explored agreement between administrative and survey data for ascertainment of seven key chronic diseases, using
individually linked data from a large population of individuals in Ontario, Canada.
Methods: All adults who completed any one of three cycles of the Canadian Community Health Survey
(2001, 2003 or 2005) and agreed to have their responses linked to provincial health administrative data were
included. The sample population included 85,549 persons. Previously validated case definitions for myocardial
infarction, asthma, diabetes, chronic lung disease, stroke, hypertension and congestive heart failure based on
hospital and physician billing codes were used to identify cases in health administrative data and these were
compared with self-report of each disease from the survey. Concordance was measured using the Kappa statistic,
percent positive and negative agreement and prevalence estimates.
Results: Agreement using the Kappa statistic was good or very good (kappa range: 0.66-0.80) for diabetes and
hypertension, moderate for myocardial infarction and asthma and poor or fair (kappa range: 0.29-0.36) for stroke,
congestive heart failure and COPD. Prevalence was higher in health administrative data for all diseases except
stroke and myocardial infarction. Health Utilities Index scores were higher for cases identified by health
administrative data compared with self-reported data for some chronic diseases (acute myocardial infarction, stroke,
heart failure), suggesting that administrative data may pick up less severe cases.
Conclusions: In the general population, discordance between self-report and administrative data was large for
many chronic diseases, particularly disease with low prevalence, and differences were not easily explained by
individual and disease characteristics.
Keywords: Chronic disease ascertainment, Health administrative data, Chronic diseases, Population health surveyBackground
In the past decade chronic diseases have emerged as the
most important health and health care problem in devel-
oped countries [1]. Accurate ascertainment of chronic
disease is essential for sound research, clinical care and
health care planning. While multiple data sources have
been used to identify persons with chronic diseases—
including population health surveys, disease registries,* Correspondence: emuggah@bruyere.org
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reproduction in any medium, provided the ormedical chart abstraction, and administrative databases—
no method has emerged as the gold standard for diagno-
sis. Increasingly, health administrative data is being used
for disease ascertainment and surveillance. While admin-
istrative data is not collected for the purposes of disease
surveillance and there are concerns about the accuracy of
the diagnostic information, it is a relatively inexpensive
method that can provide information on large populations
and can be explored overtime. In addition, administrative
data can often be compared directly with other data
sources, such as self-reported surveys, using individual
record linkage techniques. Regardless of the data source
used, there will be missed cases. The quality of thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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measurement of these errors, and correction or discussion
of biased results.
Research comparing disease ascertainment using
health administrative data with other data sources has
found that agreement between sources relies on many
factors, including individual and disease characteristics
and the specific methods applied to the data [2-6]. Most
published research has been case ascertainment valid-
ation studies of disease definitions applied to administra-
tive data to identify disease cases [3,4,7,8]. Only a few
studies have explored the accuracy of administrative data
compared with self-report of chronic conditions across
chronic conditions [9,10]. Agreement between these
sources is higher for chronic diseases that are well-
defined and require ongoing management, such as
diabetes, and is lower for poorly defined diseases such
as congestive heart failure [9,10]. Worsening comor-
bidity, measured by number of chronic conditions,
appears to be associated with lower agreement—par-
ticularly for those diseases where agreement is already
poor [11,12].
The objective of this study is to describe the validity of
administrative data compared with self-reported disease
status for the ascertainment of seven common chronic
conditions in the general population and to explore the
relationship with self-reported disease burden. This
research takes advantage of individually linked health
administrative and population survey data available for
the population of Ontario, the largest province in Canada.
Our research expands on what is known from previous
validation studies of administrative data by using the
validated disease algorithms to identify cases in the
Ontario provincial health administrative data and com-
pares prevalence estimates with the self-report of chronic
diseases in the Canadian Community Health Survey
(CCHS). A limitation of previous studies was that they
relied on typical measures of concordance such as Kappa
scores or sensitivity and specificity to determine concord-
ance; but, in the absence of a gold standard data source
and when the prevalence of a condition is particularly high
or low, these measures may not be as accurate and the
underlying patterns in the data are obscured. This study
will present a range of concordance measures to ex-
plore the validity of administrative data for disease as-
certainment. A number of diseases are examined to
explore whether concordance is similar across condi-
tions. Finally, while previous research has used a
count of chronic conditions to measure morbidity, we
explore the relationship between morbidity and con-
cordance of the data with the Health Utilities Index
(HUI) [13]. To our knowledge, this is the first time
that the HUI has been used to understand concord-
ance in disease ascertainment.Methods
This study was conducted using population based data
from the province of Ontario, Canada—with a 2011
population of more than 13 million [14]. The Institute
for Clinical Evaluative Sciences (ICES) houses the
health administrative data on hospital and physician
billings, provided by the provincial health ministry,
as well as population survey data. These data have
been individually linked using an anonymized identi-
fication number.
Population
The sample population included all adults, aged 20 years
and older, with a valid Ontario health card who com-
pleted the CCHS in 2001, 2003 or 2005, and agreed to
have their survey responses linked to their provincial
health administrative data. Residents are eligible for the
provincial health coverage if they are Canadian citizens,
landed immigrants or convention refugees, make their
permanent and principal home in Ontario, and are phys-
ically present in Ontario 153 days in any 12-month
period. A detailed flow chart of this method is included
in Additional file 1: Appendix A.
The CCHS survey uses a multi-stage, stratified, clus-
tered design. The survey uses a probability sample
and a weighting system that represents approximately
98% of the community dwelling Canadian population
aged 12 years and over. Individuals living on Indian
Reserves, institutional residents, full-time members of
the Canadian Armed Forces, and residents of certain
remote regions are excluded from the CCHS. Further




We relied on pre-existing validated case definitions, cre-
ated using Ontario hospital and physician billing codes,
for the following seven chronic diseases: diabetes, congest-
ive heart failure, myocardial infarction, stroke, hyperten-
sion, asthma, chronic obstructive lung disease (COPD)
[7,8,16-19]. The technical case definitions we used are pre-
sented in Additional file 1: Appendix B.
Canadian community health survey
The CCHS provides cross sectional estimates of health
status, health determinants and health system use for
Canadians. The survey asks respondents to identify if
they have any one of a list of chronic health conditions
which are defined as “long-term conditions that have
lasted or are expected to last six months or more and
that have been diagnosed by a health professional”.
The relevant questions from the survey are included
in Additional file 1: Appendix C.
Table 1 Demographic and clinical characteristics of
Ontarians who completed the Canadian Community
Health Survey (Cycle 1.1, 2.1, or 3.1) and agreed to link





% (totals for each
variable sum to 100%)
Sex
Male 38743 12 900 000 48.8%
Female 46806 13 500 000 51.2%
Age Group (years)
20-44 36429 13 600 000 51.3%
45-64 28508 8 620 000 32.6%
65-74 11570 2 520 000 9.5%
75+ 9042 1 730 000 6.6%
Income Quintile
1 (lowest) 17396 4 850 000 18.4%
2 17361 5 110 000 19.3%
3 17247 5 370 000 20.3%
4 17215 5 580 000 21.1%
5 (highest) 16126 5 490 000 20.8%
Missing 204 29 000 0.1%
Number of Chronic Diseases (based on health administrative data)
0 50942 17 370 000 65.7%
1 22178 6 170 000 23.3%
2 8249 2 000 000 7.6%
3 2856 625 000 2.4%
4 979 196 000 0.7%
5 270 55 000 0.2%
6+ 75 14 300 0.1%
*Population estimated using the Canadian Community Health Survey sampling
weights.
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We calculated chronic disease prevalence in the sample
population using both self-reported data and administra-
tive definitions. For self-reported prevalence, all three
cycles of the CCHS were used to identify the total number
of prevalent cases. For health administrative data disease
prevalence, case ascertainment was restricted to the time
of the administration of the CCHS survey or earlier. Raw
counts were presented for each disease in 2 × 2 tables.
Health utilities index
The self-reported health burden was measured using the
Health Utilities Index (HUI) [20]. The HUI is a prefer-
ence-based, multi-attribute health classification system
that estimates a summary value of individual health
where 0 = “dead” and 1 = “perfect health”. Each respond-
ent answers questions pertaining to eight attributes of
functional health: vision, hearing, speech, mobility, de-
xterity, emotional state, cognition and level of pain and
discomfort and these attributes are assigned individual
utility weights and then combined to create a summary
value. HUI values were only available for CCHS cycle
1.1 respondents. The HUI values were standardized for
age and sex against the 1991 Canadian population.
Analysis
Using the sample survey weights developed by Statistics
Canada, weighted prevalence estimates were calculated
to determine the total burden of each disease in Ontario
in the study time period. Population prevalence was
calculated by dividing the total weighted number of
cases (separately done for self reported and health ad-
ministrative definitions) by the total weighted popula-
tion of the cohort.
The measures of concordance presented included: sen-
sitivity (of self-report), specificity (of self-report), propor-
tion of positive and negative agreement and Cohen’s
kappa coefficient. Details on the calculation of these
measures are included in Additional file 1: Appendix D.
The kappa coefficient, a widely used as a measure of agree-
ment between raters, indicates the proportion of agree-
ment beyond that expected by chance. Levels of agreement
for kappa were considered to be poor (κ < 0.20), fair (κ =
0.20 to 0.39), moderate (κ = 0.40 to 0.59), good (κ = 0.60 to
0.79), or very good (κ = 0.80 to 1.00) [4,21].
We calculated the median and interquartile range (25th
percentile- 75th percentile) for the Health Utility Index
(HUI) only for participants in cycle 1.1 of CCHS.
All calculations were performed using SAS 9.2.
Results
The total sample included 99,108 respondents of which
85,549 were aged 20 years or older. Characteristics of the
sample population, weighted to reflect the general Ontariopopulation, are presented in Table 1. Those aged 65 years
and older made up 16.1% of the population and 34.3% of
the population had one or more chronic conditions.
The unweighted counts, prevalence, and concordance
measures are presented in Table 2. Kappa statistics
demonstrated good or very good agreement for hyperten-
sion and diabetes, moderate agreement for myocardial
infarction and asthma and poor or fair agreement for
stroke, congestive heart failure and COPD. The highest
agreement was for diabetes (Kappa 0.8). Percent positive
agreement was much lower than negative agreement
across all diseases. For example, positive agreement was
34% for COPD and 37% for stroke while percent negative
agreement was 94% and 99%, respectively.
Weighted prevalence by self-reported data was lower than
prevalence by administrative data for all diseases except
stroke and acute myocardial infarction (Table 3). Prevalence
estimates ranged from 0.7% (stroke) to 22.1% (hypertension)
for administrative data and from 1.1% (congestive heart
Table 2 Unweighted prevalence and concordance
measures for chronic diseases using health





Diabetes Yes No Total Kappa 0.80
(0.80, 0.81)
Yes 5,312 474 5,786 Sensitivity of
self-report
0.73
No 1,867 77,848 79,715 Specificity of
self-report
0.99
Total 7,179 78,322 85,501 Positive
agreement
82%






Stroke Yes No Total
Yes 433 1,020 1,453 Kappa 0.36
(0.34, 0.39)
No 453 83,592 84,045 Sensitivity of
self-report
0.49
Total 886 84,612 85,498 Specificity of
self-report
0.99









Hypertension Yes No Total
Yes 15,314 2,530 17,844 Kappa 0.66
(0.65, 0.66)
No 8,284 59,293 67,577 Sensitivity of
self-report
0.65
Total 23,598 61,823 85,421 Specificity of
self-report
0.96










AMI* Yes No Total
Yes 732 1,326 2,058 Kappa 0.48
(0.45, 0.50)
No 213 54,799 55,012 Sensitivity of
self-report
0.77
Total 945 56,125 57,070 Specificity of
self-report
0.98









Table 2 Unweighted prevalence and concordance
measures for chronic diseases using health





CHF* Yes No Total
Yes 413 458 871 Kappa 0.33
(0.30, 0.35)
No 1,151 55,042 56,193 Sensitivity of
self-report
0.26
Total 1,564 55,500 57,064 Specificity of
self-report
0.99









Asthma Yes No Total
Yes 4,620 2,742 7,362 Kappa 0.55
(0.54, 0.56)
No 3,730 74,417 78,147 Sensitivity of
self-report
0.55
Total 8,350 77,159 85,509 Specificity of
self-report
0.96












Yes 1,880 1,842 3,722 Kappa 0.29
(0.27, 0.30)
No 5,474 56,916 62,390 Sensitivity of
self-report
0.26
Total 7,354 58,758 66,112 Specificity of
self-report
0.97










*For CCHS cycle 1.1 and 2.1 — assumes ‘no’ to heart disease also means ‘no’
to AMI or CHF.
Abbreviations: AMI = acute myocardial infarction; CHF = congestive heart
failure; COPD = chronic obstructive pulmonary disease; HA = health
administrative data; SR = self-reported data.
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relative difference in prevalence estimated by the two
methods was greatest for acute myocardial infarction,
COPD, and stroke, while the relative estimates for asthma,
hypertension, and diabetes were closer.
Table 3 Prevalence of selected chronic diseases, Ontario
2001-2005







COPD 1 560 000 (8.1) 821 000 (4.3) 3 390 (0.0)
Asthma 2 530 000 (9.6) 2 070 000 (7.8) 7 380 (0.0)
CHF 312 000 (1.8) 185 000 (1.1) 18 200 (0.1)
AMI 221 000 (1.3) 449 000 (2.6) 14 200 (0.1)
Hypertension 5 840 000 (22.1) 4 410 000
(16.7)
39 500 (0.2)
Diabetes 1 890 000 (7.2) 1 440 000 (5.4) 12 700 (0.1)
Stroke 177 000 (0.7) 333 000 (1.3) 3 390 (0.0)
*Population estimated using the Canadian Community Health Survey
sampling weights.
Abbreviations: AMI = acute myocardial infarction; CHF = congestive heart
failure; COPD = chronic obstructive pulmonary disease.
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persons self-reporting with stroke to 0.93 for persons
with asthma identified on either self-report or adminis-
trative data. Self-reported cases of chronic disease had
lower median HUI scores for stroke, congestive heart
failure and acute myocardial infarction (Table 4). For all
other conditions cases identified by self-report and
health administrative data had similar HUI scores.
Discussion
We evaluated agreement between health administrative
data and self-report for ascertainment of chronic disease,
in a population of community dwelling Ontarian resi-
dents, using linked population-based data. With the
exception of acute myocardial infarction and stroke,
prevalence estimates for diseases were higher based
on health administrative data compared to self-report
data. In general, we found that there was a good level
of agreement between data sources only for diabetesTable 4 Health Utilities Index (HUI) for cases identified by
self-report and health administrative data, standardized
by age and sex
Health administrative data Self-reported data
N Median (IQR) N Median (IQR)
COPD 2,265 0.87 (0.61,0.97) 1,326 0.84 (0.56,0.97)
Asthma 2,535 0.93 (0.77,0.97) 2,452 0.93 (0.74,0.97)
CHF 743 0.78 (0.37,0.92) 444 0.66 (0.33,0.91)
AMI 430 0.91 (0.63,0.97) 946 0.83 (0.47,0.97)
Hypertension 6,860 0.91 (0.72,0.97) 5,143 0.91 (0.69,0.97)
Diabetes 2,038 0.91 (0.61,0.97) 1,672 0.91 (0.60,0.97)
Stroke 268 0.78 (0.42,0.92) 444 0.64 (0.29,0.87)
Abbreviations: AMI = acute myocardial infarction; CHF = congestive heart
failure; COPD = chronic obstructive pulmonary disease;
IQR = interquartile range.and hypertension. For the remaining diseases that were
examined, there was considerable discordance in ascer-
tainment that could only be partially explained by individ-
ual and disease characteristics. There are likely multiple
reasons for these discordances that include: disease spe-
cific biases, misclassification due to the disease definitions
used and the prevalence of the disease.
Okura proposes that diseases which are less familiar to
patients and have nonspecific and intermittent symp-
toms, such as heart failure or chronic lung disease, may
be particularly prone to underreporting by patients [12].
Conversely, administrative data may be more likely to
identify chronic diseases requiring ongoing contact with
the health care system [10,12]. This is in keeping with
our results—where disease prevalence, by health adminis-
trative data, was higher for most diseases. Our finding that
the self-reported prevalence of stroke or myocardial
infarction was higher than the prevalence from adminis-
trative data is also consistent with other studies [11,12,22].
These two diseases are commonly known in the commu-
nity and this may lead to patients falsely attributing their
symptoms to them. False-positive rates of self-reported
stroke ranging from 5% to 15% have even been reported
from specialized stroke units, mostly from patients admit-
ted with transient ischaemic attacks [23]. Rosamond et al.
found a 40% false-positive self-report of myocardial infarc-
tion among patients in a coronary care unit, primarily due
to hospitalization for unstable angina [24].
The particular question used in a survey and the case
definition employed in administrative data can also
affect ascertainment. In general, health administrative
definitions restrict to patients with hospitalization or
repeated health care contact for a disease and have a
limited look-back period. This could lead to underreport-
ing by administrative data particularly important for
“event-based” diseases such as stroke and myocardial in-
farction where “silent” events not requiring hospitalization
or events that occur outside the time period are not iden-
tified. The particular question used for ascertainment can
impact ascertainment. For example, in this study the
survey question for stroke was “do you suffer from the
consequences of a stroke” and the health administrative
data definition identified all persons admitted to the
hospital with a diagnosis of stroke or transient ischemic
attack (Additional file 1: Appendices B and C).
There is no agreement about which concordance meas-
ure is most valid when comparing ascertainment between
data sources. Level of agreement in this study varied
widely depending on the measure used particularly for the
low prevalent diseases. For example, while stroke con-
cordance was very high when comparing raw prevalence
estimates (1.0% and 1.7% for administrative and self-
report) it was only fair according to kappa (κ = 0.36). Some
concordance measures have known limitations that are
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less valid when no gold standard for diagnosis exists and
the Kappa statistic is unreliable in the setting of a signifi-
cant imbalance in the 2 × 2 table [21]. In a recent review
evaluating the quality of health administrative data,
Benchimol et al. proposed that a minimum of four statis-
tical measures should be used to assess for accuracy and
validity of administrative data source to help mitigate
these limitations [25]. Others have similarly recommended
that when measuring agreement in administrative data
researchers should report kappa, the prevalence, positive
agreement, negative agreement and relative frequency of
each cell (a, b, c and d) [26]. While there are other mea-
sures of agreement, such as the prevalence adjusted
Kappa, these may not be as accurate in the setting of low
prevalent conditions. We agree with these general guide-
lines, and we found that looking at the raw counts in
a 2 × 2 table often revealed most clearly the patterns
of discordance in a particular disease. Until the patterns of
concordance for specific diseases are more clearly under-
stood, using summary concordance measures (including
prevalence estimates) alone may obscure the underlying
patterns and should be avoided. In addition the measures
selected for concordance will need to consider the particu-
larities of the disease and population sampled.
We were particularly interested in the relationship
between morbidity and agreement. This study is the
first to present and explore the relationship of HUI, a
validated self-reported measure of overall disease
burden, to disease ascertainment. As anticipated, we
found for some conditions (myocardial infarction,
stroke and heart failure) cases identified by adminis-
trative data had higher median HUI scores (thus lower
reported morbidity) compared with self-report cases
across all diseases. For these conditions health admin-
istrative data therefore tended to identify healthier
patients than those found through self-report. While
the HUI is an overall measure of morbidity, and not a
disease-specific measure the severity, it is probable
that the severity of underlying diseases relates strongly
to overall morbidity. Our finding underscores the
need for researchers to consider the clinical signifi-
cance of cases identified by different data sources.
Stroke and congestive heart failure had the lowest
HUI scores, the largest differences in median HUI
scores, and poor concordance for the two disease
ascertainment methods; while diabetes and hyperten-
sion had high HUI scores and high concordance in
both median HUI and disease ascertainment. Previous
research has, in general, found comorbidity is asso-
ciated with poorer agreement in ascertainment
[10-12]. Our findings confirm that care should be
taken in the interpretation of disease estimates in
population with high levels of disease burden.Limitations
We acknowledge that there is no clear reference stand-
ard for the ascertainment of chronic diseases. While
clinical charts are often used to assess ascertainment
accuracy, even this approach is not a gold standard. For
example, clinic chart review for diabetes can miss cases
that are not receiving glucose lowering medications, are
not regular clinic attendees or who have their diabetes
care provided by practitioners [17]. In our view, disease
ascertainment is usually linked to disease severity, with
less severe disease often poorly ascertained. Therefore,
case ascertainment, the likelihood of truly being diag-
nosed with a disease and disease severity, health burden
from disease are all intertwined. The paucity of disease-
specific severity measures that use administrative data
reveals an important gap in knowledge in our efforts to
improve accurate ascertainment diseases using popula-
tion based data.
This study excludes a number of key chronic diseases
for which we do not yet have validated algorithms, but
we do not feel that this affects the implications of
our findings. It is clear that the relationships between
ascertainment, disease, and patient characteristics are
complex. Future analysis should consider multivariate
methods to explore the effect of these factors.
Conclusions
Population based data is a powerful tool for chronic dis-
ease surveillance. This study explored agreement between
administrative and survey data for ascertainment of seven
key chronic diseases. We found that discordance was large
for many chronic diseases, particularly disease with low
prevalence and that these differences were not easily
explained by individual and disease characteristics. In ge-
neral health administrative data tended to identify patients
who were healthier, although we were not able to com-
ment on if their disease specific morbidity was also lower.
We find that the accuracy, validity and generalizeability of
chronic disease case ascertainment methods depends on
the data source used. Researchers should be mindful as to
the implication of data source on their results.Additional file
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